Jelic MD, Mandic AD, Maricic SM, Srdjenovic BU
These include how the patient is doing, any health problems, and the testing method
In newer tests that are FDA-approved, the risk of a false negative is very low, Esplin says
GLP-1s have rapidly become first-line therapy for many patients because they directly address the underlying driver: excess fat deposition in the liver
GLP-1 also helps moderate other hormones related to blood sugar and appetite, including leptin, which signals fullness, and ghrelin, the hunger hormone. Additionally, GLP-1 slows gastric emptying, which sustains a feeling of fullness and decreases the speed at which glucose enters the bloodstream